PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1449600
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1449600
The global parenteral nutrition market was valued US$ 4,548.7 Mn in 2023 and is expected to reach US$ 7,251 Mn by 2031 growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2023/2024: | US$ 4,548.7 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 - 2031 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 6.00% | 2030/2031 Value Projection: | US$ 7,251 Mn |
Parenteral nutrition, often called total parenteral nutrition, is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to correct or prevent malnutrition. Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. People whose digestive systems either can't absorb or can't tolerate adequate food eaten by mouth use parenteral nutrition. When used outside the hospital, intravenous feeding is called home parenteral nutrition. Using home parenteral nutrition may be necessary for weeks or months, or in some cases for life. Catheter infection is a common and serious complication of parenteral nutrition. Other potential short-term complications of parenteral nutrition include blood clots, fluid and mineral imbalances, and problems with blood sugar metabolism.
The global parenteral nutrition market has been witnessing significant growth in the recent past owing to the rising prevalence of chronic diseases inducing malnutrition. Parenteral nutrition entails delivering nutrients directly into the bloodstream through an intravenous catheter when oral or enteral routes are not feasible. It finds wide application in treating malnourished patients suffering from cancer, gastrointestinal disorders, liver diseases, and other chronic conditions. Furthermore, the growing geriatric population who are more susceptible to malnutrition due to weak digestive system has also contributed to the rising demand for parenteral formulations. Various market players are engaged in developing innovative parenteral nutrition solutions to meet the treatment demands of such patient groups. However, high costs associated with parenteral feeding remains a major challenge for widespread adoption.